Alphatec (NasdaqGS:ATEC) FY Conference Transcript

Summary of Alphatec FY Conference Call (March 11, 2026) Company Overview - Company: Alphatec (NasdaqGS: ATEC) - Industry: Spine Surgery and Medical Devices Key Points Market Position and Growth Opportunities - Alphatec has made significant progress in the past year, addressing previous concerns regarding capital deployment, financing, and EBITDA, ending the year with strong cash flows and EBITDA [3][4] - The spine surgery market presents substantial growth opportunities, with Alphatec positioned as a smaller player amidst market share shifts among larger competitors [4][12] - The company believes that improving surgical outcomes through better technology will drive market share growth, as high revision rates in spine surgery indicate room for improvement [9][10] Surgeon Adoption and Utilization Metrics - Surgeon adoption rates have been around 20% over the last eight quarters, with a notable 23% in Q4 [21] - New surgeon users tend to drive mid-double-digit volume growth in subsequent years, indicating a long-term utilization improvement [21] - The average selling price (ASP) for cases is expected to grow at a low single-digit rate, reflecting increased complexity in surgeries as surgeons gain experience with Alphatec's products [22][27] Financial Performance and Cash Flow Management - The company achieved a 41% drop-through to reach approximately 12% adjusted EBITDA last year, with a guidance of 32% drop-through for the current year [64][65] - Effective management of inventory and asset deployment is crucial for supporting growth, with a target of 75 cents on the growth dollar basis [65][66] Competitive Landscape and Rep Dynamics - The competitive environment has been influenced by major players like Stryker and J&J making strategic moves, which has lowered the friction for rep transitions and increased the availability of talent [32][41][45] - The selection of new reps reflects the overall market share dynamics, with no significant over-indexing from any particular competitor [39] Technological Innovations - Alphatec is investing in enabling technologies, such as the Valence robot, which aims to enhance surgical precision and efficiency, particularly in complex procedures [50][58] - The Valence robot is positioned at a competitive price point, making it accessible for both large academic settings and community hospitals [58] Conclusion - Alphatec is confident in its growth trajectory, driven by improved surgeon adoption, innovative technologies, and effective cash flow management strategies. The company is well-positioned to capitalize on the evolving landscape of the spine surgery market [8][12][66]